49LBA Final results of a Phase II randomised study of cediranib (RECENTIN™) in patients with advanced renal cell carcinoma (RCC)

Saved in:

Bibliographic Details
Published in	European journal of cancer supplements Vol. 7; no. 3; p. 21
Main Authors	Mulders, P, Hawkins, R, Nathan, P, de Jong, I, Osanto, S, Porfiri, E, Protheroe, A, Mookerjee, B, Pike, L, Gore, M.E
Format	Journal Article
Language	English
Published	Elsevier Ltd 2009
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	1359-6349 1878-1217
DOI:	10.1016/S1359-6349(09)72084-1